BIOLASE, Inc. (BIOL)
OTCMKTS: BIOL · Delayed Price · USD
0.0687
-0.0063 (-8.40%)
Jul 19, 2024, 4:00 PM EDT - Market closed
BIOLASE Revenue
BIOLASE had revenue of $48.83M in the twelve months ending March 31, 2024, with 0.13% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $10.13M. In the year 2023, BIOLASE had annual revenue of $49.16M with 1.45% growth.
Revenue (ttm)
$48.83M
Revenue Growth
+0.13%
P/S Ratio
0.05
Revenue / Employee
$311,006
Employees
157
Market Cap
2.29M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 49.16M | 702.00K | 1.45% |
Dec 31, 2022 | 48.46M | 9.27M | 23.67% |
Dec 31, 2021 | 39.19M | 16.41M | 72.03% |
Dec 31, 2020 | 22.78M | -15.02M | -39.73% |
Dec 31, 2019 | 37.80M | -8.36M | -18.10% |
Dec 31, 2018 | 46.16M | -771.00K | -1.64% |
Dec 31, 2017 | 46.93M | -4.88M | -9.43% |
Dec 31, 2016 | 51.81M | 3.34M | 6.88% |
Dec 31, 2015 | 48.48M | 819.00K | 1.72% |
Dec 31, 2014 | 47.66M | -8.77M | -15.55% |
Dec 31, 2013 | 56.43M | -926.00K | -1.61% |
Dec 31, 2012 | 57.36M | 8.50M | 17.39% |
Dec 31, 2011 | 48.86M | 22.63M | 86.30% |
Dec 31, 2010 | 26.23M | -17.12M | -39.50% |
Dec 31, 2009 | 43.35M | -21.28M | -32.93% |
Dec 31, 2008 | 64.63M | -2.26M | -3.38% |
Dec 31, 2007 | 66.89M | -2.81M | -4.03% |
Dec 31, 2006 | 69.70M | 7.72M | 12.46% |
Dec 31, 2005 | 61.98M | 1.33M | 2.19% |
Dec 31, 2004 | 60.65M | 11.57M | 23.57% |
Dec 31, 2003 | 49.08M | 19.88M | 68.09% |
Dec 31, 2002 | 29.20M | 11.31M | 63.24% |
Dec 31, 2001 | 17.89M | 8.23M | 85.22% |
Dec 31, 2000 | 9.66M | 2.65M | 37.88% |
Dec 31, 1999 | 7.00M | 5.50M | 366.95% |
Dec 31, 1998 | 1.50M | -300.00K | -16.67% |
Dec 31, 1997 | 1.80M | 1.10M | 157.14% |
Dec 31, 1996 | 700.00K | -500.00K | -41.67% |
Dec 31, 1995 | 1.20M | 100.00K | 9.09% |
Dec 31, 1994 | 1.10M | -1.30M | -54.17% |
Dec 31, 1993 | 2.40M | -3.10M | -56.36% |
Dec 31, 1992 | 5.50M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 379.49B |
Johnson & Johnson | 81.80B |
Merck & Co. | 61.40B |
AbbVie | 54.40B |
Novartis AG | 48.86B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.49B |
Eli Lilly | 35.93B |
BIOL News
- 4 weeks ago - BIOLASE Announces Delisting from Nasdaq - Accesswire
- 2 months ago - Biolase Reports 2024 First Quarter Results; Reiterates Full-Year 2024 Guidance For Revenue Growth and Profitability - Accesswire
- 2 months ago - BIOLASE to Report First Quarter 2024 Results on May 13, 2024 - Accesswire
- 4 months ago - Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024 - Accesswire
- 4 months ago - BIOLASE to Report Fourth Quarter and Full Year 2023 Results on March 21, 2024 - Accesswire
- 5 months ago - Biolase Launches State-of-the-Art All-Tissue Laser System To Accelerate Adoption of Lasers in Dentistry - Accesswire
- 5 months ago - Biolase Announces First Quarter 2024 Webinar Series 'Lets Talk Dental' - Accesswire
- 5 months ago - BIOLASE, Inc. Announces Closing of $7.0 Million Public Offering - Accesswire